Search Results

An exhaustive, 5,000+ word master guide for Indian students, life science graduates, and working professionals moving to Ireland in 2026. Covers Stamp 2 & Stamp 1G post-study work visas, CSEP permits, university selection, VFS Global India processing, PCC, financial proof, housing scam warnings, and ethical career entry into Ireland's €100B+ biopharma sector.

The ultimate 2026 guide for international life science professionals moving between India, Ireland, the UK, and the US. Learn how to format GxP experience, CDMO backgrounds, and visa-ready ATS CVs.

Master Enterprise Ireland's funding ecosystem: from Pre-Seed Start Fund (€50k-€100k) and Innovative HPSU Fund (€1.2M) to R&D, Green, and Digitalisation vouchers. Includes step-by-step application advice, readiness timelines, and non-EU founder visa rules.

A commercial-grade blueprint for the Ireland-India pharma corridor under the EU-India FTA: tariffs, HPRA-CDSCO bridges, 2030 projections, policy asks.

An in-depth commercial analysis of the UK-India Comprehensive Economic and Trade Agreement (CETA), exploring its transformative impact on bilateral pharmaceutical manufacturing, active pharmaceutical ingredient (API) supply chains, and consumer medicine pricing.

The historic UK-India Comprehensive Economic and Trade Agreement (CETA) and Double Contributions Convention have officially entered into force, opening duty-free access for pharmaceuticals, dismantling high tariffs on manufacturing inputs, and eliminating dual social security taxes for mobile professionals.

GEODIS has renewed its IATA CEIV Pharma accreditation in Warsaw and secured GDP certification for its Stryków Dobra contract logistics facility. This dual compliance milestone bolsters Poland’s status as a critical gateway in Europe’s pharmaceutical supply chain.

NeuroBell, a spin-out from University College UCC, has closed a $5.5 million (€4.8 million) funding round led by Elkstone to secure US regulatory clearance and commercialize its AI-powered neonatal seizure detection device, Luna.

A detailed, practical guide to Ireland's Non-EEA Family Reunification Policy as updated in 2026. Covers the new financial thresholds for all sponsor categories, country-specific waiting periods, step-by-step application process, and a comprehensive pre-application checklist - essential reading for pharmacists, healthcare workers, and life science professionals bringing family to Ireland.

The Irish Department of Justice has overhauled its family reunification framework, raising the income requirement for Irish citizen sponsors to €75,000 over three years, introducing housing sufficiency checks, and imposing a new two-year waiting period for refugees. Here is everything migrants and families in Ireland need to know.

A detailed global report analyzing major pharmaceutical and biotech layoffs across the US, EU, and India from 2025 to 2026, including strategic shifts by enGene, Takeda, Bayer, and BioNTech.

Discover how the monumental EU-India Free Trade Agreement creates a market of 2 billion people. Explore its impact on tech, education, and how it will specifically propel Ireland's pharmaceutical and life sciences sector.

The June 2026 country-by-country disclosures revealed that Eli Lilly paid $6.6 billion in Irish corporation tax-double its US federal liability. We analyze why Ireland remains the ultimate hub for global pharma despite the OECD 15% minimum tax.

River turtles are more than prehistoric survivors; they are critical indicators of freshwater health. Discover the biology, ecological roles, and cutting-edge conservation technologies being used to save these sentinel species from extinction.

Cannabinoid APIs are transforming pharma with precise, plant-derived medicines, balancing sustainability, regulation, and innovation.